A detailed history of Schwerin Boyle Capital Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Schwerin Boyle Capital Management Inc holds 716,275 shares of PFE stock, worth $20 Million. This represents 2.01% of its overall portfolio holdings.

Number of Shares
716,275
Previous 584,225 22.6%
Holding current value
$20 Million
Previous $16.8 Million 18.18%
% of portfolio
2.01%
Previous 1.91%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $3.42 Million - $3.93 Million
132,050 Added 22.6%
716,275 $19.9 Million
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $313,560 - $407,280
12,000 Added 2.1%
584,225 $16.8 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $6.02 Million - $7.04 Million
-187,750 Reduced 24.7%
572,225 $19 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $27.5 Million - $31.8 Million
759,975 New
759,975 $27.9 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Schwerin Boyle Capital Management Inc Portfolio

Follow Schwerin Boyle Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schwerin Boyle Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Schwerin Boyle Capital Management Inc with notifications on news.